生物催化
工作流程
可扩展性
生化工程
工程类
工业生物技术
文件夹
纳米技术
计算机科学
资源(消歧)
嵌入
合成生物学
生物技术
管理科学
计算生物学
化学
定向进化
医药制造业
作者
Alba Díaz‐Rodríguez,Martin A. Hayes,Keith R. Mulholland,Fernando Tur,Samantha Staniland
出处
期刊:ChemBioChem
[Wiley]
日期:2026-09-14
卷期号:27 (17): e70489-e70489
摘要
Biocatalysis is becoming a strategic manufacturing capability at AstraZeneca, enabling selective transformations under milder conditions and with the potential to reduce waste and resource intensity relative to conventional routes. This review summarizes how AstraZeneca is embedding biocatalysis across the portfolio to support its long-term net-zero commitments. We describe capability building across people, through expansion of cross-site expertise, automated high-throughput experimentation platforms, and academic partnerships that extend innovation and capacity. Case studies show how enzyme identification, optimization, and directed evolution translate into robust, scalable processes for active pharmaceutical ingredients. We close by defining priorities-end-to-end automated workflows and artificial intelligence-enabled design-to shorten enzyme engineering cycles and broaden biocatalysis impact across modalities.
科研通智能强力驱动
Strongly Powered by AbleSci AI